Cleared Traditional

DELTA-A.V. FISTULA CANNULATION SET (K812621) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K812621 · Amisco Trading Corp. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1981
Decision
9d
Days
Class 2
Risk

K812621 is an FDA 510(k) clearance for the DELTA-A.V. FISTULA CANNULATION SET. Classified as Needle, Fistula (product code FIE), Class II - Special Controls.

Submitted by Amisco Trading Corp. (Mchenry, US). The FDA issued a Cleared decision on September 24, 1981 after a review of 9 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5540 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Amisco Trading Corp. devices

Submission Details

510(k) Number K812621 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 1981
Decision Date September 24, 1981
Days to Decision 9 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
121d faster than avg
Panel avg: 130d · This submission: 9d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FIE Needle, Fistula
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5540
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FIE Needle, Fistula

All 7
Devices cleared under the same product code (FIE) and FDA review panel - the closest regulatory comparables to K812621.
Dimesol Disposable AV Fistula Needle Set (Non-Safety Series) and Dimesol Disposable AV Fistula Needle Set (Safety Series)
K171505 · Dimesol, Inc. · May 2018
ARTERIOVENOUS FISTULA SETS
K900125 · Baxter Healthcare Corp · Jan 1990
DUAL FLOW NEEDLE
K832136 · Travenol Laboratories, S.A. · Oct 1983
ARGYLE A-V MEDI-WING HEMODIALYSIS SET
K801618 · Sherwood Medical Co. · Aug 1980
A.V. FISTULA NEEDLE SET
K782021 · Cordis Corp. · Mar 1979